Multifaceted role of dynamin-related protein 1 in cardiovascular disease: From mitochondrial fission to therapeutic interventions.

• Drp-1 regulates critical mitochondrial fusion and fission in cardiomyocytes. • Drp-1 influences autophagy, mitophagy, apoptosis, and necrosis via post-translational modifications. • Drp-1 activity is linked to intracellular calcium levels, impacting cellular responses to stress. • Dysregulated Drp-1 increases ROS production, leading to oxidative stress and endothelial dysfunction. • Targeting Drp-1 could improve cardiovascular outcomes by modulating mitochondrial dynamics. Mitochondria are central to cellular energy production and metabolic regulation, particularly in cardiomyocytes. These organelles constantly undergo cycles of fusion and fission, orchestrated by key proteins like Dynamin-related Protein 1 (Drp-1). This review focuses on the intricate roles of Drp-1 in regulating mitochondrial dynamics, its implications in cardiovascular health, and particularly in myocardial infarction. Drp-1 is not merely a mediator of mitochondrial fission; it also plays pivotal roles in autophagy, mitophagy, apoptosis, and necrosis in cardiac cells. This multifaceted functionality is often modulated through various post-translational alterations, and Drp-1′s interaction with intracellular calcium (Ca2 +) adds another layer of complexity. We also explore the pathological consequences of Drp-1 dysregulation, including increased reactive oxygen species (ROS) production and endothelial dysfunction. Furthermore, this review delves into the potential therapeutic interventions targeting Drp-1 to modulate mitochondrial dynamics and improve cardiovascular outcomes. We highlight recent findings on the interaction between Drp-1 and sirtuin-3 and suggest that understanding this interaction may open new avenues for therapeutically modulating endothelial cells, fibroblasts, and cardiomyocytes. As the cardiovascular system increasingly becomes the focal point of aging and chronic disease research, understanding the nuances of Drp-1′s functionality can lead to innovative therapeutic approaches. [ABSTRACT FROM AUTHOR]